drugset / Trial / NCT03030300
Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the long-term remission rate of short-term intensive insulin (STII) therapy in newly diagnosed type 2 diabetes outpatients and investigate the predictors contributing to the remission rate.
Timeline
- Start
- 2008-01
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | — |
| Subject | Metformin | Small molecule | 0.5 mg | — |
| Subject | Pioglitazone | Small molecule | 15 mg | — |